valerates has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Del Río, E; Estévez, J; González-González, M; Sogorb, MA; Vilanova, E | 1 |
| Cabrera, E; Campos, N; Girón, MD; López-Pedrosa, JM; Manzano, M; Rueda, R; Salto, R; Vílchez, JD | 1 |
2 other study(ies) available for valerates and Neuroblastoma
| Article | Year |
|---|---|
Hydrolyzing activities of phenyl valerate sensitive to organophosphorus compounds paraoxon and mipafox in human neuroblastoma SH-SY5Y cells.
Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Hydrolysis; Isoflurophate; Neuroblastoma; Organophosphorus Compounds; Paraoxon; Valerates | 2018 |
β-Hydroxy-β-Methylbutyrate (HMB) Promotes Neurite Outgrowth in Neuro2a Cells.
Topics: Animals; Brain; Glucose Transporter Type 1; Glucose Transporter Type 3; MEF2 Transcription Factors; Mice; Naphthyridines; Neurites; Neuroblastoma; Phosphorylation; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Valerates | 2015 |